Authors: PAVIA CS WORMSER GP NORMAN GL

Citation: Cs. Pavia et al., ACTIVITY OF SERA FROM PATIENTS WITH LYME-DISEASE AGAINST BORRELIA-BURGDORFERI, Clinical infectious diseases, 25, 1997, pp. 25-30

Authors: CALLISTER SM JOBE DA SCHELL RF PAVIA CS LOVRICH SD

Citation: Sm. Callister et al., SENSITIVITY AND SPECIFICITY OF THE BORRELIACIDAL-ANTIBODY TEST DURINGEARLY LYME-DISEASE - A GOLD STANDARD, Clinical and diagnostic laboratory immunology, 3(4), 1996, pp. 399-402

Authors: LIVERIS D WORMSER GP NOWAKOWSKI J NADELMAN R BITTKER S COOPER D VARDE S MOY FH FORSETER G PAVIA CS SCHWARTZ I

Citation: D. Liveris et al., MOLECULAR TYPING OF BORRELIA-BURGDORFERI FROM LYME-DISEASE PATIENTS BY PCR-RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS, Journal of clinical microbiology, 34(5), 1996, pp. 1306-1309

Authors: HOROWITZ HW PAVIA CS BITTKER S FORSETER G COOPER D NADELMAN RB BYRNE D JOHNSON RC WORMSER GP

Citation: Hw. Horowitz et al., SUSTAINED CELLULAR IMMUNE-RESPONSES TO BORRELIA-BURGDORFERI - LACK OFCORRELATION WITH CLINICAL PRESENTATION AND SEROLOGY, Clinical and diagnostic laboratory immunology, 1(4), 1994, pp. 373-378

Authors: MA JN BULGER PA DAVIS DV PERILLIPALMER B BEDORE DA KENSIL CR YOUNG EM HUNG CH SEALS JR PAVIA CS COUGHLIN RT

Citation: Jn. Ma et al., IMPACT OF THE SAPONIN ADJUVANT QS-21 AND ALUMINUM HYDROXIDE ON THE IMMUNOGENICITY OF RECOMBINANT OSPA AND OSPB OF BORRELIA-BURGDORFERI, Vaccine, 12(10), 1994, pp. 925-932

Authors: ABOLHASSANI M PAVIA CS DUNN JJ CHIAO JW

Citation: M. Abolhassani et al., A MURINE IGG1 MONOCLONAL-ANTIBODY THAT BINDS SPECIFICALLY TO OUTER SURFACE PROTEIN-A OF LYME-DISEASE SPIROCHETE BORRELIA-BURGDORFERI, FEMS microbiology letters, 109(2-3), 1993, pp. 303-309